Serum Institute, Merck & IAVI tie up to develop Covid-19 treatment therapy

Serum Institute, Merck & IAVI tie up to develop Covid-19 treatment therapy

Serum Institute of India has joined hands with Merck KGaA, Germany, and IAVI, a non-profit research organisation, to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs).
Check the source here –Source, Financial Express.

Leave your comment
Comment
Name
Email
Change Language